wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q26797535-9EE1B2F2-A0F3-44C3-A86C-B6F2836B425C
Q26797535-9EE1B2F2-A0F3-44C3-A86C-B6F2836B425C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26797535-9EE1B2F2-A0F3-44C3-A86C-B6F2836B425C
Using Modified RECIST and Alpha-Fetoprotein Levels to Assess Treatment Benefit in Hepatocellular Carcinoma
P2860
Q26797535-9EE1B2F2-A0F3-44C3-A86C-B6F2836B425C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26797535-9EE1B2F2-A0F3-44C3-A86C-B6F2836B425C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
16f1aa8473769cae9ea0f731d8c5ee03220f357e
P2860
Discovery and validation of biomarkers that respond to treatment with brivanib alaninate, a small-molecule VEGFR-2/FGFR-1 antagonist.